← FDA Drug Approvals (Drugs@FDA)

ANDA209783

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TORRENT PHARMS LLC · Approved 2018-10-16

Drug application

FDA Application #

ANDA209783

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

TORRENT PHARMS LLC

First approval

2018-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown